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Abstract
Many biological processes are controlled by both deterministic and stochastic influences. 
However, efforts to model these systems often rely on either purely stochastic or purely rule-based 
methods. To better understand the balance between stochasticity and determinism in biological 
processes a computational approach that incorporates both influences may afford additional 
insight into underlying biological mechanisms that give rise to emergent system properties. We 
apply a combined approach to the simulation and study of angiogenesis, the growth of new blood 
vessels from existing networks. This complex multicellular process begins with selection of an 
initiating endothelial cell, or tip cell, which sprouts from the parent vessels in response to 
stimulation by exogenous cues. We have constructed an agent-based model of sprouting 
angiogenesis to evaluate endothelial cell sprout initiation frequency and location, and we have 
experimentally validated it using high-resolution time-lapse confocal microscopy. ABM 
simulations were then compared to a Monte Carlo model, revealing that purely stochastic 
simulations could not generate sprout locations as accurately as the rule-informed agent-based 
model. These findings support the use of rule-based approaches for modeling the complex 
mechanisms underlying sprouting angiogenesis over purely stochastic methods.
Introduction
To understand, harness, and modulate complex systems, science must go beyond a 
deterministic cause-and-effect view of the natural world. While some biological subsystems 
may be described using rule-based methods, many must be supplemented with probabilistic 
or stochastic techniques to understand, model, and predict the outcomes of biological 
processes1–3. Randomness in model descriptions of a biological system can be included at 
three tiers: (1) the biology itself may include stochastic elements or events (e.g. gene 
expression) that are described in the model using stochastic methods2, 4, (2) measurements 
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of the biological system may introduce sampling errors that propagate random noise, which 
should be accounted for in a model to understand the underlying biological mechanism 
being sampled; or (3) underlying deterministic behavior can be modeled using validated 
stochastic approaches as a method to reduce model complexity and computational cost 
without loss of insight5, 6. Further, stochastic behavior may represent a contextual phenotype 
– a system may normally exist with strict rule-based control but then transition to stochastic 
behavior when certain conditions are met (e.g. chemokine signaling or pathological pathway 
activation)7. Alternatively, a system may be stochastic at physiological conditions but 
converted to deterministic behavior when integrated into more robust signaling network, 
such as in bacterial colony formation8, 9.
We sought to explore this balance of stochastic and rule-based behaviors in the setting of 
sprouting angiogenesis, a fundamental biological process underlying blood vessel network 
growth throughout development10. In the adult, sprouting angiogenesis has roles in both 
wound healing and endometrial vascularization. Additionally, pathologic sprouting 
angiogenesis is implicated in the expansion of solid tumors11–14, growth of ectopic 
endometrial tissue in endometriosis15, 16, and in neoangiogenesis of diabetic 
retinopathy17–19. Sprouting angiogenesis can be approximated by five main stages: (1) tip 
cell selection, (2) endothelial stalk extension, (3) stalk guidance to neighboring or nearby 
vessels, (4) anastomosis with a neighboring vessel (success) or regression/collapse to the 
originating vessel (failure), and (5) maturation and lumenization of anastomosed vessels20. 
Regardless of the final fate of the sprout, this process must begin with appropriate selection 
of a quiescent endothelial cell to undergo phenotype switching, becoming a tip cell with 
increased filopodial extension frequency. These cell behaviors, in aggregate and in 
conjunction with external signaling cues, have been presumed to dictate where new vessels 
initially form within a blood vessel network.
Regulation of endothelial phenotype switching is closely tied to several signaling pathways, 
including the well-studied Notch1/Delta-Like-Ligand 4 (DLL4) intercellular 
pathway10, 20–27, which suppresses sprout initiation, and the vascular endothelial growth 
factor receptor (VEGFR) axis that signals to increase phenotype switching and sprout 
frequency10, 28, 29. Disruption of either the suppressive pathway (Notch1/DLL4) or the 
activating pathway (VEGF/VEGFR) results in dramatic blood vessel phenotypes ranging 
from early embryonic lethality to significant vascular dysmorphogenesis (e.g. 
hypersprouting, hyperbranching phenotypes). Further, there are several isoform and 
dimerization states of VEGFRs allow for differential signaling21, 23, 28, 30, 31. In this work, 
we explore the balance between pro-angiogenic VEGFR2 and VEGFR1, which can function 
as a decoy receptor for VEGF. As such, the balance between the DLL4 and VEGFR 
signaling axes is crucial to vascular patterning. However, endothelial cell behaviors leading 
to sprout initiations in the context of intercellular signaling and capillary network 
connectivity remain unclear.
Computational models offer unique insight into the study of biological systems, enabling us 
to query unmeasurable, unobservable, or inaccessible metrics pertinent to biomedical 
science32–37. In assembling a model, the investigator is able to explicitly define methods for 
simulating each aspect of the biological processes they are modeling – either as stochastic or 
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as rule-based. Comparisons between models that assume different relative contributions of 
stochastic and rule-based behaviors empower investigation of the underlying system 
properties by contrasting the accuracy of each technique. The relevant question then 
becomes: what do we learn from modeling a system using separate rule-based and stochastic 
techniques that both provide verifiable results?
Several other computational models have been developed using primarily rule-based 
methods to explore the process of sprouting angiogenesis with single-cell and subcellular 
resolution. These include ABMs of endothelial phenotype switching that focus on filopodial 
extension and intercellular Notch1 signaling27. Bentley and colleagues have extended this 
model to bone regrowth as the multiscale model of osteogenesis and sprouting angiogenesis 
incorporating lateral inhibition of endothelial cells (MOSAIC)38, and more recently used it 
to explore endothelial cell motility in the context of the extending sprout stalk with and 
without genetic mosaics39. At the subcellular level, Hashambhoy et al. have used mass 
action kinetics models to explore VEGF diffusion, VEGFR dimerization, and surface 
signaling in simulated endothelial extensions40. Finally, Kleinstreuer et al. used a Cellular 
Potts Model to study vasculogenesis of the fetal liver with subsequent endothelial sprout 
formation as a screening tool for high throughput toxicology analysis41. Though the specific 
approaches differ, these models all sufficiently capture and explore the possibility for a 
deterministic (or rule-informed) basis for cellular behaviors in sprouting angiogenesis at 
multiple resolutions. However, while these rule-based approaches are certainly valid, they 
do not compare their results to stochastic alternatives that may be similarly predictive of 
biological behavior.
Here, we describe a new agent based model (ABM) of angiogenic sprout initiation informed 
by high-resolution dynamic spatial and temporal data from the three-dimensional embryoid 
body (EB) model of embryogenesis42. Our ABM includes Notch1-DLL4 and VEGF 
signaling within and between cells to predict the frequency and location of endothelial 
sprout initiation events in image-based realistic multicellular networks and is validated 
against the data from the EB time-lapse movies. This is the first report of validating an ABM 
one-to-one with dynamic data of angiogenic sprouts. Further, we constructed a Monte Carlo 
simulation as a benchmark for asserting accuracy of sprout localization using purely 
stochastic methods. By comparing the rule-based ABM to the Monte Carlo we demonstrate 
that rule-based models more accurately simulate endothelial cell sprout initiation location. 
This combined approach supports the hypothesis that the location of sprout initiations in 




Maintenance and differentiation of mouse embryonic stem (ES) cells was described 
previously.43 Stable expression of PECAM-eGFP in ES cell lines was previously reported.44 
Real-time imaging of day 7–8 differentiating ES cell cultures was conducted as follows: 
confocal images were acquired at 4–10 min intervals for 16–20 hr with an Olympus 
FluoView FV1000 or FV10i system (full environmental controls) using either a 10× or 20× 
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objective. At each location, a z-stack of 6–8 images was acquired with 4–6 microns between 
focal planes. These images were compressed post-acquisition into a single frame for each 
time point.
Agent based model
Agent and time definitions—The ABM was built using Netlogo 5.0 and data were 
analyzed using MATLAB45, 46. Each endothelial cell (EC) is spatially defined by eight 
membrane nodes (mNode) and a single centroid “nucleus” linked to each membrane node; 
the mNodes are connected to each other by membrane links (Figure 1A). The two-
dimensional space occupied by cells is discretized into 10 µm × 10 µm pixels. During the 
course of the simulation the each cell adjusts its shape to approach an average endothelial 
cell surface area (ECSA, Table 1); this is achieved by having links convey movement 
between their attached nodes – when a node is moved all linked nodes attempt to follow but 
may be hindered by other links. The time step of the simulation is 24 minutes, enough time 
to resolve micron-scale changes in cell position and still capture changes in protein levels47 
(Figure 2).
Modeling molecular biology: VEGF and DLL4 signaling axes—Each pixel stores 
concentration values of soluble VEGFR1 (sVEGFR1) and VEGF. sVEGFR1 is secreted by 
endothelial cells and in this simulation are produced by the mNodes. VEGF is secreted by 
cells throughout the tissue and therefore is produced by the pixels in this model. Diffusion is 
included using a simple distribution command – 25% of each diffusible species in each pixel 
is equally distributed among its eight neighboring pixels (Moore neighborhood).
Receptor binding kinetics are assumed to be 1:1 interactions between dimerized VEGFRs 
and dimeric VEGF48, 49– if a pixel contains VEGF and also includes either (1) an mNode 
with membrane-bound VEGFR1 (mVEGFR1), (2) an mNode with VEGFR2, or (3) 
sVEGFR1, then binding will occur until one of the pools (ligand or receptor) is completely 
depleted. For example, if there 10 molecules of VEGF and 100 available VEGFR2, the 
ABM will remove all VEGF from the pixel, while the local mNode reduces VEGFR2 to 90, 
and adds 10 phosphorylated VEGFR2 (pR2). When binding sVEGFR1 or mVEGFR1 there 
is no downstream function – receptor-ligand complexes are removed from the cell surface 
without further impact on signaling. These binding rules do not account for equilibria or 
mass action kinetics, favoring simpler, lower resolution molecular interactions at the 
multicellular scale. When VEGFR2 is converted to pR2 it increases the DLL4 production in 
that cell, following the formula:
(1)
where DLL4t+1 expression level is defined as the current amount of DLL4t, increased by 
activation of pR2, and decreased at a constant degradation rate (Figure 2).
Based on what is known about the molecular biology of these families in endothelial cells, 
production rates of the VEGFRs are directly related to DLL4 expression on neighboring 
cells by the formula:
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where ẋ is the production rate per time-step of receptor x, and xmin and xmax are the 
minimum and maximum production rates, respectively. The DLL4 content of each 
neighboring cell (defined as having an intercellular link between mNodes) is summed and 
then scaled by the Notch1 transfer coefficient α. When α is 0 there is no information transfer 
between neighboring cells. Notch1 signaling alters the transcriptional regulation of 
VEGFRs, increasing the production of both sVEGFR1 and mVEGFR1 and decreasing the 
production of VEGFR2 (Figure 2). VEGFR production rates are updated with each time-
step.
Initial production rates for VEGF and VEGFRs are estimated based on literature-derived 
values (Table 1). In the case of Notch1 and DLL4, the initial values were set at 0 and 
instantiated based on Equation 2 and basal production rates. Minimum and maximum 
production rates (xmin and xmax, respectively) were estimated to be two orders of magnitude 
above and below the basal production rate.
Phenotype switch from quiescent to tip cell—When the pR2 levels on an endothelial 
cell in the model are above the tip cell activation threshold (β, Table 1) they undergo 
transition to the tip cell phenotype. Activated tip cells respond to VEGF signaling via 
chemotaxis towards the nearest source of VEGF. To calculate the direction of movement, 
the cell determines the mNode with highest pR2, and moves in the direction of the 
neighboring pixel with the highest VEGF concentration. This ability to sense VEGF 
concentrations at a distance of up to 10 µm accounts for the effects of filopodial extension 
without explicitly modeling individual filopodia in the ABM. Endothelial cells in the tip cell 
state that drop below the tip cell activation threshold return to a quiescent phenotype.
Rendering embryoid body data as ABM geometries—Projections of confocal 
image stacks were converted to 16-bit intensity maps and loaded into the ABM using a 
custom image processing program written in Netlogo (Figure 1B). Loaded images were then 
converted to starting ABM configurations by manually selecting cell locations and then 
allowing for membrane shape change to approach the average endothelial cell surface area, 
ECSA. Using the EB image as a guide, each cell mNode could be manually edited to better 
match the geometric configuration of the fluorescence intensity data. The EB image was 
then cleared and the resulting vessel geometry file exported for use in simulations (Figure 
1B).
Parameter estimation of Notch Transfer Coefficient—From each of three EB 
movies a quadrant was selected and used as training data to determine the Notch Transfer 
Coefficient (α, Equation 2) for subsequent simulations. Simulation of sprouting using these 
starting configurations was performed over a parameter range from 0 to 2 in increments of 
0.2, yielding a total of 16 different parameter values, each evaluated in 20 replicate ABM 
simulation runs. The number of sprout initiations over the course of each simulation was 
compared to raw sprout initiation counts from the paired EB movie and the best fit Notch 
Transfer Coefficient value was determined.
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The Notch Transfer Coefficient value that generated the best fit from the parameterization 
was then validated in seven additional, independent EB Movie quadrants to confirm its 
accuracy and robustness across different initial network geometries. An example of true 
positive predictions as compared to false positives is shown in Figure 4B.
Sensitivity analysis—A local approach was used to evaluate sensitivity to the ABM 
Notch Transfer Coefficient: all other variables were held constant while sampling the 
parameter space of the Notch Transfer Coefficient between 0 and 2.0 using a 0.2 step size. A 
total of 20 simulations were run at each parameter value for each of the eleven total starting 
geometries defined by EB Movie quadrants.
Monte Carlo analysis of stochastic sprouting without molecular control—For 
each EB movie quadrant, Monte Carlo simulations wer performed using Netlogo. Unlike the 
ABM, the Monte Carlo simulation randomly selects endothelial cells to undergo phenotype 
switch to tip cells (i.e. this method does not include the molecular mechanisms of VEGF and 
Notch1 signaling). The cells chosen were selected from a uniform distribution with 
replacement – this allowed the same cell to be chosen to be a tip cell more than once, as 
might occur in the ABM or EB model if a tip cell becomes quiescent and then reactivates at 
a later time point. The Monte Carlo simulations were not tasked with predicting the number 
of sprout initiation events; rather, the number of sprout initiation events (i.e. number of tip 
cell selection events) was drawn from a normal distribution with mean and standard 
deviation taken from ABM predictions. Each EB movie quadrant was evaluated over 1000 
replicates.
The set of available sprout initiation locations available to the Monte Carlo simulation was 
bounded by the location of endothelial cells in the starting configurations of each EB movie 
quadrant. A performance index was defined as the difference between true positive 
frequencies in the ABM and Monte Carlo analyses – a positive value indicates better 
predictive performance of the ABM whereas a negative value indicates better predictive 
power of the Monte Carlo simulation.
Genetic algorithm—A genetic algorithm (GA) was applied to four parameters of the 
ABM (Notch Transfer Coefficient, tip cell activation threshold, sVEGFR1 production rate, 
and mVEGFR1 production rates) with the goal of maximizing the true positive frequency of 
the worst performing simulation, using the following objective function:
(3)
where XTP is the true positive rate achieved by the ABM using a set of parameter values xn. 
Minimum values for each parameter (xn in Equation 3) were set to zero while maximum 
values were set to 100× the initial parameter value (Table 1). The simulation was run for 190 
generations with 20 ABM replicates at each generation to determine an average true positive 
frequency.
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Statistical analysis—Confidence intervals, Pearson’s correlation, and partial least 
squares regression analysis were performed using GraphPad Prism version 5.0d for Mac 
OSX. Unless otherwise stated, significance was asserted at P ≤ 0.05.
Results
ABM Notch Transfer Coefficient parameter estimation
Lacking a literature-derived value for the Notch Transfer Coefficient (α, Equation 2), the 
key parameter governing the strength of Notch1 intercellular signaling, necessitated the use 
of parameter estimation. A single quadrant from each of three independent EB movies was 
evaluated over 16 different Notch Transfer Coefficient (α) parameter values (Figure 3D). As 
the strength of Notch lateral inhibition increases (increasing α), the number of sprout 
initiations occurring over the course of the simulations decreases, as would be expected. 
Above a value of α = 1.6 all three simulated movie quadrants converged to 0 sprout 
initiation events, effectively preventing any phenotype switching. Conversely, when the 
Notch Transfer Coefficient parameter was maintained at 0, no lateral inhibition was 
possible, and every cell in the simulation attempted to sprout. A Notch Transfer Coefficient 
parameter of approximately 0.6 resulted in agreement between the ABM predictions of 
sprout initiations and the observed sprout initiations in the three training quadrants (Figure 
3D).
ABM simulates sprout initiation frequency
We sought to validate the Notch Transfer coefficient value of 0.6 established by parameter 
estimation with 3 training EB movie quadrants. To achieve this, 8 additional test EB movie 
quadrants were analyzed (Figure 3E). For all but one simulation (M3Q3), the observed 
number of sprout initiations in the corresponding EB movie quadrant fell within the ABM 
predicted 95% confidence interval of sprout initiations. This discrepancy for M3Q3 may be 
due to having a high number of sprout initiations occurring in close proximity in the EB 
movies – two sprout initiations that occur in close proximity may be underestimated by the 
ABM which predicts only one sprout initiation.
Sensitivity of ABM to Notch Transfer Coefficient parameter
All EB movie quadrants were evaluated for sensitivity to the Notch Transfer Coefficient. 
Across the range of tested parameter values (α = 0.0–2.0) all simulated vessel networks 
demonstrated a sprout initiation frequency that was inversely proportional to the Notch 
Transfer Coefficient (Figure 3F). Further, we performed a bidirectional sensitivity analysis 
for sprout initiation frequency, simultaneously varying both the Notch Transfer Coefficient 
(α) and the tip cell activation threshold (β). While the sensitivity to the Notch Transfer 
Coefficient is preserved across values of the tip cell activation threshold, the latter 
demonstrates less of an affect on the former (Figure S1). In all EB movies, the sprout 
initiation frequency was less sensitive to the tip cell activation threshold than the Notch 
Transfer Coefficient.
Despite variations in vessel network morphology such as number of endothelial cells and 
vessel length density (Figure 3A–C), all simulated movie responses could be estimated using 
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linear functions within the parameter range from 0.0 to 1.0 (Figure 3G) with coefficients of 
determination greater than 0.80 for all simulations except one (M3Q3, R2 = 0.70) and with 
non-zero slopes that were statistically significant (p < 0.05). These data demonstrate 
sensitivity to the Notch Transfer Coefficient across all tested EB movie vessel networks
Use of a Monte Carlo model to evaluate accuracy of ABM-simulated sprout initiation 
locations
The trued positive frequency of ABM sprout initiation locations was scored using the 
methods described in Figure 1B. A Monte Carlo analysis was performed to determine the 
likelihood of correctly predicting sprout initiation locations purely by random chance, given 
the mean and standard deviation of paired ABM simulation sprout initiation events as input. 
The frequency of true positive events (determined by comparison to the observed sprout 
initiations in the EB movies) as generated by Monte Carlo simulation was compared to that 
of the ABM in the range of sprout initiation frequency when the Notch Transfer Coefficient 
parameter is set to 0.6 (Figure 4A).
Using the difference in true positive frequency as a performance index we demonstrated that 
the ABM has higher spatial accuracy in 7 of 11 starting geometries (Figure 4B). There 
appeared to be no correlation between performance index and initial conditions of the EB 
movie networks, such as number of sprout initiations, number of starting endothelial cells, 
vessel length density, or sprout initiation density (Figure 4C–F).
Unsupervised parameter identification in ABM using GA
The parameter values used in the ABM simulations were literature-derived values (Table 1), 
with the exception of the Notch Transfer Coefficient, which was estimated (Figure 3). 
However, it is possible that a set of optimal parameters could improve the performance 
index of the ABM simulations. To explore this possibility, we used an unsupervised 
approach to search for a set of parameter values that could maximize the true positive 
frequency of the simulation with the worst performance index, M1Q1 (Figure 4B).
We used a GA to identify, in an unsupervised manner, the values of four key parameters 
(Notch Transfer Coefficient, tip cell activation threshold, sVEGFR1 production rate, 
VEGFR1 production rate, Equation 3) over the range from 0 to 100 times their original 
simulation values. As shown in Figure 5A the true positive frequency of the GA derived 
parameter values approach 40% accuracy. This rank ordering of all generations 
demonstrates four populations of outcomes: zero accuracy (no sprout initiations), low 
accuracy (less than 10%), medium accuracy (10%), and the highest accuracy (40%). 
Notably, these are all less than the original true positive frequency of the ABM 
(approximately 60%, Figure 4A).
Of interest, the GA obtained its best results when minimizing the tip cell activation threshold 
for phenotype switch from quiescent endothelium to tip cell. Conversely, reduced values of 
the Notch Transfer Coefficient (α) were associated with poorer performing populations 
(Figure 5C). Additionally, for the highest true positive frequency population (defined as 
>36%), the average value of α was 0.63 (Figure 5B), in agreement with the parameter 
estimation performed in Figure 3.
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The GA derived production rates of mVEGFR1 and sVEGFR1 were both approximately six 
orders of magnitude higher than the values used in Table 1, with the ratio of soluble to 
membrane bound production being 1.6 (data not shown).
Conclusions
With the advent of innovations in intravital microscopy, such as light sheet microscopy, 
confocal, and multi-photon microscopy, imaging dynamic processes in living tissues and in 
ex vivo engineered tissue model systems has become more feasible50–52. These approaches 
generate data-rich movies that capture the dynamic behaviors of cells as they migrate within 
tissues and form multicellular structures, such as blood vessels53–55. Viewing movies of 
tissue morphogenesis prompts the observer to ask a number of questions about underlying 
mechanisms, such as: are these behaviors defined by rule-based pathways? Are they the 
result of stochastic biological noise? Or, perhaps, are they controlled by some combination 
of both rule-based and stochastic influences? By combining computational modeling with 
confocal imaging we have attempted to address these questions in the context of angiogenic 
sprouting. We compared two different modeling approaches: (1) an ABM in which 
endothelial cell behaviors are governed by a set of rules and (2) a Monte Carlo simulation 
with purely stochastic cell behaviors, uninformed by signaling pathways.
In developing our ABM, we had to make several simplifying assumptions. In particular, 
diffusion and binding kinetics play important roles in signaling through the VEGFR family, 
including homo- and heterodimerization states that were not included in the ABM. 
Furthermore, VEGF itself was modeled as a single diffusive isoform with properties similar 
to the VEGF121 splice variant that lacks a heparin binding domain31. We feel these 
assumptions are valid in the context of simulating the locations and frequencies of sprout 
initiations; however, simulating subsequent steps in sprouting angiogenesis, such as 
extension of the sprout away from its parent blood vessel, would likely require more high-
resolution simulation of these molecular pathways, incorporating the physics of particle 
diffusion and mass action kinetics40, 48, 49. Furthermore, a similar irreversible binding 
kinetics model has been suggested for the related Epidermal Growth Factor (EGF) 
membrane-bound polypeptide signaling receptor complex56. It is important to note that 
while the ABM simulations are driven by deterministic rules, diffusion of VEGF was 
modeled as a stochastic process, allowing for variation in receptor binding for each 
simulation.
Additionally, the ABM demonstrates sensitivity to the Notch Transfer Coefficient with a 
response region that can be approximated by a linear response with a non-zero slope. This 
permits tuning of the model to additional experimental conditions. For example, decreasing 
the Notch Transfer Coefficient parameter mimics inhibition of the Notch1-DLL4 pathway 
and produces increased sprout initiations as would be expected by small molecule inhibition 
(e.g. the gamma-secretase inhibitor DAPT)23, 57.
The Monte Carlo simulation, with no molecular mechanisms included, was constructed to 
compare a purely stochastic method of modeling endothelial cell behavior against ruled-
based ABM-generated sprout initiation locations. Whereas we could directly compare the 
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number of sprout initiations simulated by the ABM to the number of sprout initiations 
observed in the EB movies, there was no gold standard for evaluating the accuracy of sprout 
initiation locations. The Monte Carlo provided a benchmark for assigning a performance 
index (Figure 4B) of ABM accuracy as compared to the accuracy of random chance.
We demonstrate that the ABM accounting for Notch1-DLL4 lateral inhibition under control 
of VEGFR regulation is capable of simulating the frequency of angiogenic sprout initiations 
within the EB (Figure 3E). Despite disparate initial endothelial cell network configurations 
from one EB movie to the next (Figure 3A–C), the ABM predicted the correct number of 
sprout initiation events in all but one of the EB movie quadrants. Further, the ABM 
outperforms the Monte Carlo simulation of endothelial sprout initiation location in 7 of 11 
EB movies (Figure 4B), strongly suggesting that deterministic rules are necessary for 
accurately simulating sprout initiation locations.
Using a GA, we attempted to improve the performance of an ABM with the lowest 
performance index as defined by the Monte Carlo. Four key parameters were selected and 
systematically tested by the GA to maximize the ABM true positive accuracy for that movie 
quadrant (Equation 3). Despite the use of this optimization algorithm, there was no 
improvement in the ABM’s ability to accurately simulate sprout locations. Note that the 
objective function employed (Equation 3) does not penalize for false positive predictions – 
our primary use of the GA was to test for a parameter set that improved upon our literature-
derived values for predicting sprout initiations. As an alternative, using an objective function 
that negatively weighted false positives would potentially provide a more constrained 
parameter set. Nevertheless, as compared to the values obtained in an unsupervised manner 
by the GA using a less conservative objective function, literature-derived parameter values 
are better approximations of the underlying biological processes that they describe.
Taken together, our use of a Monte Carlo simulation and a GA optimization algorithm to 
score ABM performance and attempt to improve upon that performance, respectively, lead 
us to conclude that inclusion of additional biological mechanisms in future iterations of the 
ABM may be necessary to improve its predictive capabilities. We speculate that the addition 
of new rules accounting for the presence of perivascular cells, for example, or that simulate 
VEGF molecular diffusion and receptor binding at the cell surface with higher spatial 
resolution, may extend the ABM’s capabilities.
Others have also begun to explore how accurately angiogenic sprouting can be modeled by 
purely stochastic methods. Silva et al. recently investigated the frequency of sprouting 
events in a fibrin bead assay by comparison to a theoretical Poisson distribution and 
demonstrated that this probabilistic approach consistently underestimated sprout 
frequency58. They concluded that enrichment with “efficient” sprouting endothelial cells 
was responsible for the discrepancy – indeed, isolation of a population of endothelial cells 
expressing low levels of CD143 and subsequent analysis in bead sprouting assays 
demonstrated significant increase in sprout frequency over both control (mixed) and isolated 
“inefficient” sprouting cells. Thus, after demonstrating that a probabilistic model 
insufficiently captured the features of fibrin bead sprouting, a new hypothesis – the 
existence of populations of endothelial cells with differential sprouting capacity – was 
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generated and tested. Including this new rule-based cellular behavior (efficient or inefficient 
sprouting) into the theoretical Poisson distribution generated sprout frequency predictions in 
agreement with experimentally observed results. Our present study is consistent with theirs, 
and suggests that probabilistic models that lack the inclusion of rule-based mechanisms may 
be insufficient for accurately simulating sprouting angiogenesis.
Our manuscript represents a first step towards greater understanding of sprouting 
angiogenesis through the integration of ex vivo, dynamic imaging techniques and 
computational simulations with both rule-based and stochastic methods. Our ABM uses a 
minimal set of rules to simulate, with considerable accuracy, the frequency and locations of 
endothelial sprout initiations in the EB during sprouting angiogenesis. By comparing ABM 
to Monte Carlo predictions, we were able to quantitate the spatial accuracy of the ABM and 
evaluate whether or not unsupervised parameter exploration improved its performance. 
Moreover, our simulations suggested that deterministic rules that account for key biological 
mechanisms are better able to recapitulate experimentally observed angiogenic sprout 
initiations than random chance, suggesting that rule-based influences predominate over 
stochastic influences in this setting of embryonic vascular development.
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Construction of ABM from experimental time-lapse movies. Each cell is comprised of 
multiple agents including mNodes, nuclei, inter-, and intra-cellular links as shown in the 
cartoon (A). The embryoid body movie’s initial frame is converted to an ABM 
representation to match EC locations. Simulation predictions of sprout initiations (circles) 
are then compared to observed sprout initiations from the EB movie (squares) and scored as 
true positive or false positive (B).
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ABM workflow. Each of the main subroutines occur sequentially at every time step: section 
and binding, rate adjustment, and phenotype switching and chemotaxis.
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Parameterization and validation of ABM based on a diverse population of EB Movies. The 
vessel network characteristics of each EB Movie are not uniform and represent a diverse 
sampling of possible EC network architectures (A–C). Using three EB Movies the ABM 
Notch Transfer Coefficient was parameterized to predict the number of sprout initiations 
(D). The Notch Transfer Coefficient value of 0.6 was then tested in all other EB Movies. 
The number of sprout initiations observed in the EB Movies (red squares) is shown to fall 
within the 95% confidence interval of ABM predictions (black circles and error bars, E). 
Perfoming the same sweep of the Notch Transfer Coefficient from 0.0 through 2.0 for all EB 
Movies demonstrates a similar trend, possessing a linear response region from 0.0 to 1.0 
(shaded region is one standard deviation, F,G).
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Comparing ABM and Monte Carlo predictions of sprout initiation locations. For each 
movie, the Monte Carlo (red) and ABM (black) prediction of sprout initiations (x-axis) and 
true positive frequency (y-axis) were compared (SEM, A). A performance index, defined as 
the difference between ABM and Monte Carlo true positive frequency, was calculated. The 
ABM outperforms the Monte Carlo simulation in 7 out of 11 EB Movie simulations (Green 
Bars, B). C–F, Metrics of EC network structure from each EB Movie plotted as a function of 
the performance index; no correlation could be discerned.
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Parameter optimization using genetic algorithm to improve performance index. The true 
positive frequency for each generation was plotted in increasing rank order to highlight four 
distinct outcome populations: no sprouting, low-, medium-, and high-populations (mean ± 
SD, A). The Notch Transfer Coefficient (α) was plotted using the same rank-ordered 
generations and found to approach a value of 0.6 (B). To achieve improved true positive 
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frequency the genetic algorithm attempted to minimize the tip cell activation threshold for 
phenotype switch from quiescent EC to tip cell (C).
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Table 1
ABM Parameter Values
Parameter Description Value Reference
ECSA EC Surface Area 962E-8 cm2 59
dsVEGFR1 Initial sVEGFR1 Secretion Rate 2.8E-10 nmol cm−2 ·s−1 40
dmVEGFR1 Initial mVEGFR1 Insertion Rate 2.8E-10 nmol cm−2 ·s−1 40
dVEGFR2 Initial VEGFR2 Insertion Rate 8.4E-10 nmol cm−2 ·s−1 48
dVEGF VEGF Production Rate 5.0E-10 nmol cm−2 ·s−1 40
dDLL4 Initial DLL4 Insertion Rate 0 Estimated
dNOTCH Initial Notch Insertion Rate 0 Estimated
xmin Minimum insertion rate 1.0E-12 nmol cm−2 ·s−1 Estimated
xmax Maximum insertion rate 1.0E-8 nmol cm−2 ·s−1 Estimated
ECctx Chemotactic Migration Rate 30 µm ·h−1 Estimated from47, 60, 61
α Notch Transfer Coefficient Model Specific Parameter Fit
β Tip Cell Activation Threshold Model Specific Estimated
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Table 2
Summarized ABM Rules
Rules Key Parameters Reference
Endothelial cells migrate towards the highest concentration of VEGF, based on VEGFR2 activation ECctx 10, 47, 60–62
Increased VEGFR2 activation increases DLL4 expression 57, 63, 64
DLL4 activates Notch1, resulting in decreased VEGFR2 expression α 57, 63
mVEGFR1 and sVEGFR1 act as a decoy receptors to reduce local VEGF concentrations 30, 65
VEGFR2 activation induces a tip cell phenotype characterized by increased EC sprouting β 10, 66
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